Management of spasticity in cerebral palsy
Subtitle: the role of intrathecal baclofen
By: editors, L. Andrew Koman, Beth Paterson Smith ; contributors, Kat Kolaski ... [et al.].
Contributors: Koman, L. Andrew.; Smith, Beth Paterson.; Kolaski, Kat.
Edition: 1st ed.
Publisher: Data Trace Pub., Co.
Published: 2005
Place of publication: Brooklandville, Md
Language: eng
Subjects: Cerebral palsy -- Chemotherapy.; Spasticity -- Chemotherapy.; Antispasmodics.; Injections, Spinal.; Cerebral Palsy -- drug therapy.; Cerebral Palsy -- physiopathology.; Baclofen -- administration & dosage.; Baclofen -- therapeutic use.; Injections, Spinal -- contraindications.; Injections, Spinal -- methods.; Muscle Spasticity -- drug therapy.; Treatment Outcome.
Table of contents: title: Anatomy and pathophysiology / L. Andrew Koman, Beth Paterson Smith; title: Evaluation of spasticity / L. Andrew Koman, Beth Paterson Smith; title: Outcome assessment / L. Andrew Koman, Beth Paterson Smith; title: The spasticity management team / Kat Kolaski; title: Nonpharmacologic and oral pharmacologic management of spasticity / L. Andrew Koman, Beth Paterson Smith, and Kat Kolaski; title: Parenteral management options / L. Andrew Koman ... [et al.]; title: Musculoskeletal surgery and rhizotomy / L. Andrew Koman, Beth Paterson Smith, and Jeffrey S. Shilt; title: Pharmacology and pharmacokinetics; title: Patient selection for / Kat Kolaski; title: Surgical technique, postoperative care, and complications / Jeffrey Shilt, Normann Cabrera; title: Medical management of ITB patients / Kat Kolaski; title: Medical complications of ITB: overdose and withdrawal / Kat Kolaski; title: Outcomes of ITB and effects on the natural history of cerebral palsy / Kat Kolaski; title: Development of an effective ITB program / Kat Kolaski, MD, Jeffrey S. Shilt.